The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…
Read More
FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
The U.S. Food and Drug Administration (FDA) has officially reversed its earlier decision regarding Moderna’s investigational mRNA influenza vaccine (mRNA-1010),…
Read More
FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts
Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read More
FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance on Moderna’s innovative mRNA influenza vaccine candidate,…
Read More
FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design
Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…
Read More
FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
In a significant development for vaccine innovation and public health, the U.S. Food and Drug Administration (FDA) has reversed its…
Read More
The modification of lipid nanoparticles with aromatic rings and disulfide bonds enhances mRNA vaccine delivery.
Researchers at the University of Pennsylvania (PA, USA) have achieved a significant breakthrough in mRNA vaccine technology, modifying lipid nanoparticles…
Read More
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna, a leading biotechnology company known for its pioneering work in mRNA technology, has been dealt a significant setback by…
Read More
FDA reverses course, agrees to review Moderna’s mRNA flu vaccine
The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance, agreeing to review Moderna’s messenger RNA (mRNA)…
Read MoreYOU MAY HAVE MISSED
